Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.
| 0 | |
| 0 | |
| - | |
| 0 | |
| 0 | |
| 0-0 | |
| 4 914 | |
| 49 137 K | |
| 15 792 K | |
| -0.015 | |
| -161.727 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Accelerates and bolsters expansion of additive manufacturing offerings for dental applications EDEN PRAIRIE, Minn. & REHOVOT, Israel, December 07, 2021--(BUSINESS WIRE)--Stratasys Ltd. (NASDAQ: SSYS)...
VANCOUVER, British Columbia, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces that it has filed ...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
